These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1868700)

  • 21. Apparent vaccine-thimerosal induced hypersensitivity, myelodysplastic syndrome and pancytopenia.
    Karsen H; Akdeniz H; Karahocagil MH; Baran AI; Erten R
    J Infect Dev Ctries; 2007 Dec; 1(3):348-9. PubMed ID: 19734619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The positivity of thimerosal in Greece.
    Katsarou A; Lambrinopoulou K; Armenaka M
    Contact Dermatitis; 1999 Nov; 41(5):291-2. PubMed ID: 10554068
    [No Abstract]   [Full Text] [Related]  

  • 23. Thimerosal exposure in infants and developmental disorders: a prospective cohort study in the United kingdom does not support a causal association.
    Heron J; Golding J;
    Pediatrics; 2004 Sep; 114(3):577-83. PubMed ID: 15342824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sensitization to thimerosal (Merthiolate) is still present today.
    van 't Veen AJ; van Joost T
    Contact Dermatitis; 1994 Nov; 31(5):293-8. PubMed ID: 7867326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Erythema multiforme due to diphtheria-pertussis-tetanus vaccine.
    Karincaoğlu Y; Aki T; Erguvan-Onal R; Seyhan M
    Pediatr Dermatol; 2007; 24(3):334-5. PubMed ID: 17542900
    [No Abstract]   [Full Text] [Related]  

  • 26. Thimerosal is a frequent sensitizer but is not in the standard series.
    Aberer W; Kränke B
    Contact Dermatitis; 1995 Jun; 32(6):367-8. PubMed ID: 7554892
    [No Abstract]   [Full Text] [Related]  

  • 27. Ethylmercuric chloride: the responsible agent in thimerosal hypersensitivity.
    Pirker C; Möslinger T; Wantke F; Götz M; Jarisch R
    Contact Dermatitis; 1993 Sep; 29(3):152-4. PubMed ID: 8222628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between thimerosal-containing vaccine and autism.
    Hviid A; Stellfeld M; Wohlfahrt J; Melbye M
    JAMA; 2003 Oct; 290(13):1763-6. PubMed ID: 14519711
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thimerosal exposure (from tetanus-diphtheria vaccine) during pregnancy and neurodevelopment of breastfed infants at 6 months.
    Marques RC; Dórea JG; Bernardi JV
    Acta Paediatr; 2010 Jun; 99(6):934-9. PubMed ID: 20003103
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An assessment of thimerosal use in childhood vaccines.
    Ball LK; Ball R; Pratt RD
    Pediatrics; 2001 May; 107(5):1147-54. PubMed ID: 11331700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Mercury in vaccines].
    Hessel L
    Bull Acad Natl Med; 2003; 187(8):1501-10. PubMed ID: 15146581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of the Joint Statement by the American Academy of Pediatrics/US Public Health Service on thimerosal in vaccines on hospital infant hepatitis B vaccination practices.
    Hurie MB; Saari TN; Davis JP
    Pediatrics; 2001 Apr; 107(4):755-8. PubMed ID: 11335754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thimerosal-containing vaccines: evidence versus public apprehension.
    DeStefano F
    Expert Opin Drug Saf; 2009 Jan; 8(1):1-4. PubMed ID: 19236212
    [No Abstract]   [Full Text] [Related]  

  • 34. [Source and clinical significance of allergy for thiomersal, an organic mercury compound].
    van 't Veen AJ; van Joost T
    Ned Tijdschr Geneeskd; 1996 Feb; 140(6):297-300. PubMed ID: 8720702
    [No Abstract]   [Full Text] [Related]  

  • 35. Thimerosal: a hidden allergen in ophthalmology.
    Tosti A; Tosti G
    Contact Dermatitis; 1988 May; 18(5):268-73. PubMed ID: 3416589
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective screening for thimerosal hypersensitivity: a pilot study.
    Gordon A
    Am J Optom Physiol Opt; 1988 Mar; 65(3):147-50. PubMed ID: 3364522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inactivated influenza vaccine (IIV) in children <2 years of age: examination of selected adverse events reported to the Vaccine Adverse Event Reporting System (VAERS) after thimerosal-free or thimerosal-containing vaccine.
    McMahon AW; Iskander JK; Haber P; Braun MM; Ball R
    Vaccine; 2008 Jan; 26(3):427-9. PubMed ID: 18093701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autism and thimerosal-containing vaccines: lack of consistent evidence for an association.
    Stehr-Green P; Tull P; Stellfeld M; Mortenson PB; Simpson D
    Am J Prev Med; 2003 Aug; 25(2):101-6. PubMed ID: 12880876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Questions about thimerosal remain.
    Mann JR
    Exp Biol Med (Maywood); 2003 Oct; 228(9):991-2; discussion 993-4. PubMed ID: 14530505
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral lichenoid lesions caused by allergy to mercury in amalgam fillings.
    Pang BK; Freeman S
    Contact Dermatitis; 1995 Dec; 33(6):423-7. PubMed ID: 8706402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.